Comparison of atypical antipsychotics for recovery in schizophrenia

Comparison of atypical antipsychotics for recovery in schizophrenia - CARS study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021800

Enrollment

300

Registered

2016-05-05

Start date

2016-05-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

asenapine olanzapine blonanserin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) criteria for primary diagnosis of schizophrenia obtein the patient's informed consent using some documents who can be treated following the protocol

Exclusion criteria

Exclusion criteria: treatment resistant schizophrenia suffering from a potentially deadly disease history of convulsive disorders such as epilepsy, or organic brain syndrome parkinson's disease diabetes history of neuroleptic malignant syndrome history of substance abuse pregnancy or breastfeeding women

Design outcomes

Primary

Measure	Time frame
Changes in PANSS scores.	—

Countries

Japan

Contacts

Public ContactHiroki Beppu

University of Occupational and Environmental Health department of psyciatry, school of medecine

hirokibeppu@med.uoeh-u.ac.jp093-691-7253

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026